Cite
[Gemcitabine: from preclinic to clinic passing by pharmacokinetics]
MLA
François, Lokiec, and Lansiaux Amélie. “[Gemcitabine: From Preclinic to Clinic Passing by Pharmacokinetics].” Bulletin Du Cancer, Sept. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........167307b163fdf499ef166fa57a97c00c&authtype=sso&custid=ns315887.
APA
François, L., & Amélie, L. (2007). [Gemcitabine: from preclinic to clinic passing by pharmacokinetics]. Bulletin Du Cancer.
Chicago
François, Lokiec, and Lansiaux Amélie. 2007. “[Gemcitabine: From Preclinic to Clinic Passing by Pharmacokinetics].” Bulletin Du Cancer, September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........167307b163fdf499ef166fa57a97c00c&authtype=sso&custid=ns315887.